Given the results of our and previous research groups regarding immunosuppressive activity of myeloid cells and their clinical relevance [2, 5, 32], we next compared expression of PD-L1 on M-MDSC and monocytes/macrophages in the three TMEs of ovarian cancer patients with different clinicopathologic features. This evidence concerns the gene CD274 and ovarian cancer.